Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hip Dislocation, Congenital | 1 | 2005 | 9 | 0.230 |
Why?
|
| Osteoarthritis, Hip | 1 | 2005 | 22 | 0.230 |
Why?
|
| Femur | 1 | 2005 | 105 | 0.220 |
Why?
|
| Orthopedic Equipment | 1 | 2003 | 4 | 0.200 |
Why?
|
| Ethylene Oxide | 1 | 2003 | 2 | 0.200 |
Why?
|
| Transducers, Pressure | 1 | 2003 | 6 | 0.200 |
Why?
|
| Sterilization | 1 | 2003 | 6 | 0.200 |
Why?
|
| Manometry | 1 | 2003 | 42 | 0.200 |
Why?
|
| Equipment Failure Analysis | 1 | 2003 | 87 | 0.200 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 195 | 0.190 |
Why?
|
| Hip Prosthesis | 2 | 2012 | 28 | 0.140 |
Why?
|
| Prosthesis Failure | 2 | 2012 | 116 | 0.140 |
Why?
|
| Postoperative Complications | 6 | 2012 | 2552 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 168 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2003 | 99 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2018 | 2434 | 0.100 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2012 | 3 | 0.090 |
Why?
|
| Chromium | 1 | 2012 | 17 | 0.090 |
Why?
|
| Cobalt | 1 | 2012 | 31 | 0.090 |
Why?
|
| Heparin | 1 | 1991 | 177 | 0.080 |
Why?
|
| Venous Thrombosis | 2 | 2006 | 257 | 0.080 |
Why?
|
| Intraoperative Period | 2 | 2005 | 93 | 0.080 |
Why?
|
| Warfarin | 2 | 1999 | 106 | 0.070 |
Why?
|
| Thrombosis | 1 | 1991 | 308 | 0.070 |
Why?
|
| Anticoagulants | 3 | 2006 | 455 | 0.070 |
Why?
|
| Carrier State | 1 | 2008 | 40 | 0.070 |
Why?
|
| Arthroplasty, Replacement | 1 | 2008 | 32 | 0.070 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2008 | 83 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 236 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 284 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2005 | 172 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 148 | 0.050 |
Why?
|
| Compressive Strength | 1 | 2003 | 23 | 0.050 |
Why?
|
| Bone Cements | 1 | 2003 | 11 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 107 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 750 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2006 | 350 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 833 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2012 | 10128 | 0.040 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 1999 | 7 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1909 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 1697 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 3814 | 0.030 |
Why?
|
| Arthroplasty | 1 | 2018 | 36 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 1999 | 403 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2705 | 0.030 |
Why?
|
| Humans | 12 | 2018 | 93130 | 0.030 |
Why?
|
| Child | 1 | 2005 | 7273 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 5900 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2005 | 9070 | 0.020 |
Why?
|
| Ions | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2008 | 494 | 0.020 |
Why?
|
| Male | 7 | 2008 | 44353 | 0.020 |
Why?
|
| Spinal Diseases | 2 | 1985 | 96 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2012 | 293 | 0.020 |
Why?
|
| Female | 6 | 2008 | 48540 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 696 | 0.020 |
Why?
|
| Mupirocin | 1 | 2008 | 5 | 0.020 |
Why?
|
| Adult | 4 | 2005 | 27849 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2008 | 91 | 0.020 |
Why?
|
| Aged | 6 | 2008 | 20395 | 0.020 |
Why?
|
| Intervertebral Disc | 1 | 1985 | 30 | 0.010 |
Why?
|
| Aftercare | 1 | 2006 | 89 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 284 | 0.010 |
Why?
|
| Titanium | 1 | 2003 | 27 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2003 | 4546 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2003 | 201 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 3044 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 1999 | 42 | 0.010 |
Why?
|
| Bandages | 1 | 1999 | 42 | 0.010 |
Why?
|
| Middle Aged | 4 | 2008 | 27535 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 1978 | 19 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1999 | 315 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1978 | 46 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1999 | 232 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1999 | 655 | 0.010 |
Why?
|
| Panniculitis, Nodular Nonsuppurative | 1 | 1977 | 1 | 0.010 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1977 | 12 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 7039 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1999 | 1925 | 0.010 |
Why?
|
| Time Factors | 1 | 1999 | 5380 | 0.010 |
Why?
|
| Chymopapain | 1 | 1985 | 5 | 0.000 |
Why?
|
| Spinal Nerve Roots | 1 | 1985 | 20 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 241 | 0.000 |
Why?
|
| Back Pain | 1 | 1985 | 73 | 0.000 |
Why?
|
| Intervertebral Disc Displacement | 1 | 1985 | 48 | 0.000 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1985 | 90 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 269 | 0.000 |
Why?
|
| Recurrence | 1 | 1985 | 1188 | 0.000 |
Why?
|
| Myelography | 1 | 1978 | 10 | 0.000 |
Why?
|
| Methods | 1 | 1978 | 135 | 0.000 |
Why?
|
| Neural Conduction | 1 | 1978 | 71 | 0.000 |
Why?
|
| Iliac Artery | 1 | 1978 | 41 | 0.000 |
Why?
|
| Lumbosacral Region | 1 | 1978 | 57 | 0.000 |
Why?
|
| Laminectomy | 1 | 1978 | 61 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1978 | 90 | 0.000 |
Why?
|
| Leg | 1 | 1978 | 139 | 0.000 |
Why?
|
| Electromyography | 1 | 1978 | 198 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1978 | 106 | 0.000 |
Why?
|
| Blood Protein Disorders | 1 | 1977 | 7 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1977 | 94 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 2562 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1978 | 1519 | 0.000 |
Why?
|
| Phenotype | 1 | 1977 | 2545 | 0.000 |
Why?
|